查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球消化道內視鏡導絲市場 - 2023-2030年
市場調查報告書
商品編碼
1297828

全球消化道內視鏡導絲市場 - 2023-2030年

Global GI Endoscopy Guidewire Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球消化道內視鏡導絲市場在2022年達到2.575億美元，預計到2030年將見證有利可圖的成長，達到3.499億美元。在預測期間（2023-2030年），全球消化道內視鏡導絲市場預計將呈現4.5%的複合成長率。

導絲有各種長度和直徑，通常由不銹鋼或類似材料組成。它通過內視鏡的附屬通道或工作通道插入，使內視鏡醫生能夠將其推進到消化道內的目標區域。

市場動態

越來越多的消化道疾病篩查正在推動全球消化道內視鏡導絲市場在預測期間的成長。

篩查率的提高，特別是結直腸癌的篩查，是由於公眾對早期識別和篩查消化道疾病的價值認知的提高。在結腸鏡等篩查過程中，經常需要使用導絲，建議超過一定年齡或有一定風險因素的人使用。在這些手術中對導絲的需求隨著篩查率的上升而上升。

如果消化道內視鏡檢查發現異常，在某些情況下可能需要採取治療措施。治療工具，如活體組織切片鉗、切除息肉的鉗子，或治療狹窄或狹窄的支架，都可以由導絲引導。對治療性干涉的需求和導絲的使用都隨著篩查率的提高而上升。

意識和教育的增加為消化道內視鏡導絲提供了市場成長機會。

消化道內視鏡導絲使用的上升是針對消化道疾病（如結腸癌）的活動的結果。這些活動包括篩查運動、公共衛生運動以及利益相關者和醫療機構的合作。這些活動通過提高意識和鼓勵早期發現，鼓勵更多的人進行消化道內視鏡檢查程序，包括需要導絲的程序。在疑難病例的治療過程中，內視鏡由導絲引導，實現精確的可視化和可靠的診斷。隨著重點計劃的推廣，消化道內視鏡導絲的需求預計會增加，促進患者更好的治療效果和消化道疾病的早期治療。

COVID-19影響分析

COVID-19大流行病對消化道內視鏡導絲市場產生了重大影響。 COVID-19的大流行增加了人們對醫療機構安全和感染控制的擔憂。內視鏡設施和醫院採取了更嚴格的措施，包括增加使用個人防護設備（PPE），改進清潔程序，以及改變病人流動程序。雖然是必要的，但這些行動增加了醫療機構的開支和後勤困難，這可能對導絲的接受和使用產生影響。

俄羅斯-烏克蘭衝突分析

俄烏戰爭對消化道內視鏡導絲市場的影響是複雜和多方面的。在受影響的地區，暴力嚴重破壞了醫療系統。醫院和其他醫療機構的可及性可能受到影響，影響了內視鏡治療和相關設備，如導絲的可用性。

目錄

第一章：方法和範圍

  • 研究方法
  • 報告的研究目標和範圍

第二章：定義和概述

第三章：執行摘要

  • 按材料摘錄
  • 按適應症分類
  • 按設計分類
  • 按終端用戶分類
  • 按地區分類

第4章：動態變化

  • 影響因素
    • 驅動因素
      • 越來越多的人採用微創療法
    • 限制因素
      • 缺少訓練有素的專業人員
    • 機會
      • 技術進步
    • 影響分析

第五章：行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 未滿足的需求
  • 監管分析

第六章：COVID-19分析

  • 對COVID-19的分析
    • COVID-19之前的情況
    • COVID-19期間的情況
    • COVID-19之後的情況
  • 在COVID-19期間的定價動態
  • 需求-供應譜系
  • 大流行期間與市場有關的政府計劃
  • 製造商的戰略計劃
  • 結語

第7章：俄羅斯-烏克蘭戰爭分析

第八章：人工智慧分析

第九章：按材料分類

  • 不銹鋼
  • 鎳鈦合金
  • 其他材料

第十章：按適應症分類

  • ERCP
  • 上消化道內視鏡檢查
  • 內視鏡超聲(EUS)
  • 結腸鏡檢查

第十一章：按設計分類

  • 單絲線
  • 盤狀鋼絲
  • 帶塗層或護套的鋼絲

第十二章：按終端用戶分類

  • 醫院
  • 研究實驗室和學術機構
  • 其他用戶

第十三章：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東和非洲

第十四章：競爭格局

  • 競爭格局
  • 產品標杆
  • 公司佔有率分析
  • 主要發展和戰略

第十五章：公司簡介

  • Boston Scientific Corporation
    • 公司概述
    • 產品組合和說明
    • 財務概況
    • 主要發展情況
  • CONMED Corporation
  • COOK MEDICAL Inc
  • HOBBS MEDICAL INC
  • Olympus Corporation
  • Medico's-Hirata Inc
  • Sumitomo Bakelite Co., Ltd
  • Diagmed Healthcare
  • Omnimed Ltd
  • Merit medical systems, Inc

第16章：附錄

簡介目錄
Product Code: MD3450

Market Overview

The Global GI Endoscopy Guidewire Market reached US$ 257.5 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 349.9 million by 2030. The Global GI Endoscopy Guidewire Market is expected to exhibit a CAGR of 4.5% during the forecast period (2023-2030).

The guidewire comes in a variety of lengths and diameters and is often composed of stainless steel or comparable material. It is inserted through an accessory channel or working channel of the endoscope, allowing the endoscopist to advance it into the targeted area within the GI tract.

Market Dynamics

Increasing Screening for GI Diseases Are Boosting The Global GI Endoscopy Guidewire Market Growth During The Forecast Period.

Increased screening rates, particularly for colorectal cancer, are the result of growing public awareness of the value of early identification and screening for GI diseases. The use of guidewires is frequently necessary during screening procedures like colonoscopies, which are advised for those over a certain age or who have a certain set of risk factors. The need for guidewires in these operations rises as screening rates do.

Therapeutic measures may be necessary in some instances if GI endoscopic tests reveal abnormalities. Therapeutic tools like biopsy forceps, snares for removing polyps, or stents for narrowing or strictures can all be guided by guidewires. The demand for therapeutic interventions and the use of guidewires both rise with higher screening rates.

Increasing Awareness And Education Provide GI Endoscopy Guidewire With Market Growth Opportunities.

The rising use of GI endoscopy guidewires is a result of targeted activities for GI disorders such as colorectal cancer. These programs include screening campaigns, public health campaigns, and stakeholder and healthcare provider partnerships. These campaigns encourage more people to have GI endoscopy procedures, including those requiring guidewires, by increasing awareness and encouraging early detection. Endoscopes are guided by guidewires during therapeutic treatments in difficult cases, enabling precise visualization and reliable diagnosis. The need for GI endoscopic guidewires is anticipated to increase as focused initiatives spread, promoting better patient outcomes and the early treatment of GI disorders.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the GI Endoscopy Guidewire market. The COVID-19 pandemic increased worries about safety and infection control in healthcare facilities. Stricter measures were put in place by endoscopy facilities and hospitals, including increased use of personal protective equipment (PPE), improved cleaning procedures, and altered patient flow procedures. Although required, these actions increased expenses and logistical difficulties for healthcare facilities, which can have an impact on guidewire acceptance and use.

Russia-Ukraine Conflict Analysis

The impact of the Russia-Ukraine war on the GI endoscopy guidewire market is complex and multifaceted. In the impacted areas, the violence has severely disrupted the healthcare system. The accessibility of hospitals and other medical institutions may have been compromised, affecting the availability of endoscopic treatments and associated equipment, such as guidewires.

Segment Analysis

The global GI endoscopy guidewire market is segmented based on material, indication, design, end-user, and region.

The Colonoscopy Segment Is Expected To Hold A Dominant Position In The Market Over The Forecast Period.

The colonoscopy segment accounted for the highest market stake accounting for approximately 39.6% of the GI endoscopy guidewire market in 2022. The large intestine (colon) is examined using a colonoscopy, a frequent diagnostic and therapeutic technique, to look for anomalies including polyps, tumors, or inflammation. Although they are not frequently utilized in colonoscopies, guidewires may be used in some circumstances. A guidewire may occasionally be used during a colonoscopy to help the endoscope pass through difficult anatomical variations, strictures, or convoluted sections of the colon. The endoscope can be guided and advanced through the colon with the aid of the guidewire.

Geographical Analysis

Increasing Collaborations And Partnerships Among The Key Players, And Advancement in GI Endoscopy Guidewire Dominate the European Region.

Europe is expected to dominate the GI endoscopy guidewire market, accounting for around 26.8% of this market. The market players are offering the products in the region to strengthen their business in the European region. For instance, the Barr 360 express RFA balloon catheter, Barr 360 RFA balloon catheter, and the Barr 360 soft-sizing balloon can all be exchanged with the use of Barr RFA endoscopic guidewires.

Competitive Landscape

The major global players in the market include: Boston Scientific Corporation, CONMED Corporation, COOK MEDICAL Inc, HOBBS MEDICAL INC, Olympus Corporation, Medico's-Hirata Inc, Sumitomo Bakelite Co., Ltd, Diagmed Healthcare, Omnimed Ltd, and Merit medical systems among others.

Why Purchase the Report?

  • To visualize the global GI endoscopy guidewire market segmentation based on the material, indication, design, end-user, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous GI endoscopy guidewire market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global GI endoscopy guidewire market report would provide approximately 68 tables, 69 figures, and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Material
  • 3.2. Snippet by Indication
  • 3.3. Snippet by Design
  • 3.4. Snippet by End-user
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising adoption of minimally invasive therapies
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of trained professionals
    • 4.1.3. Opportunity
      • 4.1.3.1. Technological advancements
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Analysis

9. By Material

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.1.2. Market Attractiveness Index, By Material
  • 9.2. Stainless Steel*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Nitinol
  • 9.4. Others

10. By Indication

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.1.2. Market Attractiveness Index, By Indication
  • 10.2. ERCP*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Upper-GI endoscopy
  • 10.4. Endoscopic Ultrasound (EUS)
  • 10.5. Colonoscopy

11. By Design

    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 11.1.2. Market Attractiveness Index, By Design
  • 11.2. Monofilament Wires*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Coiled Wires
  • 11.4. Coated or Sheathed Wires

12. By End-user

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 12.1.2. Market Attractiveness Index, By End-user
  • 12.2. Hospitals*
    • 12.2.1. Introduction
    • 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3. Research Laboratories & Academic Institutes
  • 12.4. Others

13. By Region

  • 13.1. Introduction
    • 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 13.1.2. Market Attractiveness Index, By Region
  • 13.2. North America
    • 13.2.1. Introduction
    • 13.2.2. Key Region-Specific Dynamics
    • 13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.2.7.1. The U.S.
      • 13.2.7.2. Canada
      • 13.2.7.3. Mexico
  • 13.3. Europe
    • 13.3.1. Introduction
    • 13.3.2. Key Region-Specific Dynamics
    • 13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.3.7.1. Germany
      • 13.3.7.2. The U.K.
      • 13.3.7.3. France
      • 13.3.7.4. Italy
      • 13.3.7.5. Spain
      • 13.3.7.6. Rest of Europe
  • 13.4. South America
    • 13.4.1. Introduction
    • 13.4.2. Key Region-Specific Dynamics
    • 13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.4.7.1. Brazil
      • 13.4.7.2. Argentina
      • 13.4.7.3. Rest of South America
  • 13.5. Asia-Pacific
    • 13.5.1. Introduction
    • 13.5.2. Key Region-Specific Dynamics
    • 13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.5.7.1. China
      • 13.5.7.2. India
      • 13.5.7.3. Japan
      • 13.5.7.4. Australia
      • 13.5.7.5. Rest of Asia-Pacific
  • 13.6. Middle East and Africa
    • 13.6.1. Introduction
    • 13.6.2. Key Region-Specific Dynamics
    • 13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user

14. Competitive Landscape

  • 14.1. Competitive Scenario
  • 14.2. Product Benchmarking
  • 14.3. Company Share Analysis
  • 14.4. Key Developments and Strategies

15. Company Profiles

  • 15.1. Boston Scientific Corporation*
    • 15.1.1. Company Overview
    • 15.1.2. Product Portfolio and Description
    • 15.1.3. Financial Overview
    • 15.1.4. Key Developments
  • 15.2. CONMED Corporation
  • 15.3. COOK MEDICAL Inc
  • 15.4. HOBBS MEDICAL INC
  • 15.5. Olympus Corporation
  • 15.6. Medico's-Hirata Inc
  • 15.7. Sumitomo Bakelite Co., Ltd
  • 15.8. Diagmed Healthcare
  • 15.9. Omnimed Ltd
  • 15.10. Merit medical systems, Inc

LIST NOT EXHAUSTIVE

16. Appendix

  • 16.1. About Us and Services
  • 16.2. Contact Us